Ventral pallidal injections of a mu antagonist block the development of behavioral sensitization to systemic morphine

Citation
Pi. Johnson et Tc. Napier, Ventral pallidal injections of a mu antagonist block the development of behavioral sensitization to systemic morphine, SYNAPSE, 38(1), 2000, pp. 61-70
Citations number
71
Categorie Soggetti
Neurosciences & Behavoir
Journal title
SYNAPSE
ISSN journal
08874476 → ACNP
Volume
38
Issue
1
Year of publication
2000
Pages
61 - 70
Database
ISI
SICI code
0887-4476(200010)38:1<61:VPIOAM>2.0.ZU;2-N
Abstract
Acute activation of opioid receptors in the ventral pallidum increases moto r behaviors in rats. The present study was designed to investigate the poss ibility that the ventral pallidum influences motor responses induced by chr onic opiate treatments and to examine the receptors that may be involved in such are effect. For five consecutive days, ambulations were quantified af ter rats received once-daily intraperitoneal (i.p.) injections of morphine (10 mg/kg) or saline following bilateral intra-ventral pallidal injections of either saline (0.5 mu l/hemisphere), the mu antagonist CTOP (2.1 mu g/0. 5 mu l/hemisphere), or the D1 antagonist SCH23390 (0.25 mu g/0.5 mu l/hemis phere). Behavioral sensitization to an acute morphine challenge (10 mg/kg i .p.) was assessed 72 h after terminating the repeated treatment regimen. Ra ts who repeatedly received the intra-ventral pallidal saline + i.p. morphin e exhibited increases in ambulations during the chronic treatment protocol and this effect was greatly enhanced (i.e., sensitized) following the post withdrawal acute morphine challenge; Rats repeatedly treated with intra-ven tral pallidal CTOP + i.p. morphine did not display a motor response either during the chronic treatment regime or to the acute morphine challenge; an effect not seen when CTOP was injected into brain structures located dorsal to the ventral pallidum. The rats repeatedly treated with intra-ventral pa llidal injections of SCH23390 + i.p. morphine demonstrated a motor response during the chronic protocol but the magnitude of this response was not sig nificantly enhanced by the acute morphine challenge. These results demonstr ate that: 1) mu opioid and D1-like dopamine receptors in the ventral pallid um influence the increase in locomotion that occurs during repeated morphin e treatments; and. 2) mu opioid (but not D1) receptors in the ventral palli dum are important in the postwithdrawal sensitized response to morphine. Su ch observations indicate that the ventral pallidum plays a critical role in morphine-induced behavioral sensitization. Synapse 38:61-70, 2000. (C) 200 0 Wiley-Liss, Inc.